nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.12	0.188	CbGbCtD
Hydromorphone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0636	0.0999	CbGbCtD
Hydromorphone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0636	0.0999	CbGbCtD
Hydromorphone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0581	0.0914	CbGbCtD
Hydromorphone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0581	0.0914	CbGbCtD
Hydromorphone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0518	0.0814	CbGbCtD
Hydromorphone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0488	0.0767	CbGbCtD
Hydromorphone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0482	0.0757	CbGbCtD
Hydromorphone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.033	0.0518	CbGbCtD
Hydromorphone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0314	0.0494	CbGbCtD
Hydromorphone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.028	0.044	CbGbCtD
Hydromorphone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0164	0.0258	CbGbCtD
Hydromorphone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0155	0.0244	CbGbCtD
Hydromorphone—Naloxone—TLR4—chronic obstructive pulmonary disease	0.00307	0.546	CrCbGaD
Hydromorphone—Dextromethorphan—CHRNA3—chronic obstructive pulmonary disease	0.00165	0.293	CrCbGaD
Hydromorphone—Dextromethorphan—SLC6A4—chronic obstructive pulmonary disease	0.000517	0.0919	CrCbGaD
Hydromorphone—Naloxone—ALB—chronic obstructive pulmonary disease	0.000384	0.0682	CrCbGaD
Hydromorphone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000995	CcSEcCtD
Hydromorphone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00099	CcSEcCtD
Hydromorphone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00099	CcSEcCtD
Hydromorphone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.000981	CcSEcCtD
Hydromorphone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.000981	CcSEcCtD
Hydromorphone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.000981	CcSEcCtD
Hydromorphone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.000981	CcSEcCtD
Hydromorphone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000978	CcSEcCtD
Hydromorphone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.000978	CcSEcCtD
Hydromorphone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000275	0.000977	CcSEcCtD
Hydromorphone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.000977	CcSEcCtD
Hydromorphone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.000976	CcSEcCtD
Hydromorphone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000275	0.000976	CcSEcCtD
Hydromorphone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000972	CcSEcCtD
Hydromorphone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000972	CcSEcCtD
Hydromorphone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00097	CcSEcCtD
Hydromorphone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000273	0.000969	CcSEcCtD
Hydromorphone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.000968	CcSEcCtD
Hydromorphone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000968	CcSEcCtD
Hydromorphone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000968	CcSEcCtD
Hydromorphone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.000964	CcSEcCtD
Hydromorphone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00096	CcSEcCtD
Hydromorphone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.000957	CcSEcCtD
Hydromorphone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000955	CcSEcCtD
Hydromorphone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000948	CcSEcCtD
Hydromorphone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000944	CcSEcCtD
Hydromorphone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.000941	CcSEcCtD
Hydromorphone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.000935	CcSEcCtD
Hydromorphone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.000931	CcSEcCtD
Hydromorphone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000262	0.000931	CcSEcCtD
Hydromorphone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.000926	CcSEcCtD
Hydromorphone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.000926	CcSEcCtD
Hydromorphone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000924	CcSEcCtD
Hydromorphone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.000923	CcSEcCtD
Hydromorphone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000918	CcSEcCtD
Hydromorphone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000914	CcSEcCtD
Hydromorphone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00091	CcSEcCtD
Hydromorphone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.000909	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.000908	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000255	0.000908	CcSEcCtD
Hydromorphone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000254	0.000901	CcSEcCtD
Hydromorphone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.000901	CcSEcCtD
Hydromorphone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.000897	CcSEcCtD
Hydromorphone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.000896	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00025	0.000889	CcSEcCtD
Hydromorphone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000888	CcSEcCtD
Hydromorphone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000888	CcSEcCtD
Hydromorphone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000249	0.000886	CcSEcCtD
Hydromorphone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.000886	CcSEcCtD
Hydromorphone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000248	0.000883	CcSEcCtD
Hydromorphone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.000879	CcSEcCtD
Hydromorphone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.000877	CcSEcCtD
Hydromorphone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.000877	CcSEcCtD
Hydromorphone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000247	0.000876	CcSEcCtD
Hydromorphone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.000873	CcSEcCtD
Hydromorphone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000868	CcSEcCtD
Hydromorphone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000244	0.000868	CcSEcCtD
Hydromorphone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000244	0.000866	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00086	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00086	CcSEcCtD
Hydromorphone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.000859	CcSEcCtD
Hydromorphone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000242	0.000859	CcSEcCtD
Hydromorphone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.000859	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.000857	CcSEcCtD
Hydromorphone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00024	0.000852	CcSEcCtD
Hydromorphone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.000852	CcSEcCtD
Hydromorphone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.000852	CcSEcCtD
Hydromorphone—Pain—Formoterol—chronic obstructive pulmonary disease	0.00024	0.000852	CcSEcCtD
Hydromorphone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.000851	CcSEcCtD
Hydromorphone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000849	CcSEcCtD
Hydromorphone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000849	CcSEcCtD
Hydromorphone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.000845	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000237	0.000843	CcSEcCtD
Hydromorphone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000237	0.000841	CcSEcCtD
Hydromorphone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000839	CcSEcCtD
Hydromorphone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.000836	CcSEcCtD
Hydromorphone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000235	0.000835	CcSEcCtD
Hydromorphone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.000832	CcSEcCtD
Hydromorphone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000828	CcSEcCtD
Hydromorphone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.000825	CcSEcCtD
Hydromorphone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.000825	CcSEcCtD
Hydromorphone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000231	0.000821	CcSEcCtD
Hydromorphone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.000821	CcSEcCtD
Hydromorphone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00082	CcSEcCtD
Hydromorphone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000818	CcSEcCtD
Hydromorphone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00023	0.000816	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.000815	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000229	0.000815	CcSEcCtD
Hydromorphone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000814	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000812	CcSEcCtD
Hydromorphone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.000811	CcSEcCtD
Hydromorphone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000804	CcSEcCtD
Hydromorphone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000804	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000225	0.000798	CcSEcCtD
Hydromorphone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000798	CcSEcCtD
Hydromorphone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000223	0.000791	CcSEcCtD
Hydromorphone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.000791	CcSEcCtD
Hydromorphone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000222	0.000788	CcSEcCtD
Hydromorphone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000222	0.000788	CcSEcCtD
Hydromorphone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.000788	CcSEcCtD
Hydromorphone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.000788	CcSEcCtD
Hydromorphone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000785	CcSEcCtD
Hydromorphone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.000785	CcSEcCtD
Hydromorphone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000779	CcSEcCtD
Hydromorphone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.000778	CcSEcCtD
Hydromorphone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.000778	CcSEcCtD
Hydromorphone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.000778	CcSEcCtD
Hydromorphone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000775	CcSEcCtD
Hydromorphone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.000775	CcSEcCtD
Hydromorphone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.000773	CcSEcCtD
Hydromorphone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000773	CcSEcCtD
Hydromorphone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000771	CcSEcCtD
Hydromorphone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000771	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.000769	CcSEcCtD
Hydromorphone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000759	CcSEcCtD
Hydromorphone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000756	CcSEcCtD
Hydromorphone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000747	CcSEcCtD
Hydromorphone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000744	CcSEcCtD
Hydromorphone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000744	CcSEcCtD
Hydromorphone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.000734	CcSEcCtD
Hydromorphone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000207	0.000734	CcSEcCtD
Hydromorphone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.000733	CcSEcCtD
Hydromorphone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000732	CcSEcCtD
Hydromorphone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000202	0.000719	CcSEcCtD
Hydromorphone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000201	0.000715	CcSEcCtD
Hydromorphone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.000715	CcSEcCtD
Hydromorphone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.000705	CcSEcCtD
Hydromorphone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000198	0.000705	CcSEcCtD
Hydromorphone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000704	CcSEcCtD
Hydromorphone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0007	CcSEcCtD
Hydromorphone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000694	CcSEcCtD
Hydromorphone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000693	CcSEcCtD
Hydromorphone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00069	CcSEcCtD
Hydromorphone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.000682	CcSEcCtD
Hydromorphone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000192	0.000682	CcSEcCtD
Hydromorphone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000678	CcSEcCtD
Hydromorphone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.000675	CcSEcCtD
Hydromorphone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000672	CcSEcCtD
Hydromorphone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000188	0.000668	CcSEcCtD
Hydromorphone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000666	CcSEcCtD
Hydromorphone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000661	CcSEcCtD
Hydromorphone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000659	CcSEcCtD
Hydromorphone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000659	CcSEcCtD
Hydromorphone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000182	0.000645	CcSEcCtD
Hydromorphone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000644	CcSEcCtD
Hydromorphone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000635	CcSEcCtD
Hydromorphone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000633	CcSEcCtD
Hydromorphone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000633	CcSEcCtD
Hydromorphone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.000628	CcSEcCtD
Hydromorphone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000177	0.000628	CcSEcCtD
Hydromorphone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000177	0.000628	CcSEcCtD
Hydromorphone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.000628	CcSEcCtD
Hydromorphone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000624	CcSEcCtD
Hydromorphone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000624	CcSEcCtD
Hydromorphone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000624	CcSEcCtD
Hydromorphone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000623	CcSEcCtD
Hydromorphone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000622	CcSEcCtD
Hydromorphone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00062	CcSEcCtD
Hydromorphone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000173	0.000615	CcSEcCtD
Hydromorphone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000173	0.000615	CcSEcCtD
Hydromorphone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000613	CcSEcCtD
Hydromorphone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000613	CcSEcCtD
Hydromorphone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000172	0.000611	CcSEcCtD
Hydromorphone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.000604	CcSEcCtD
Hydromorphone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000598	CcSEcCtD
Hydromorphone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000596	CcSEcCtD
Hydromorphone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000594	CcSEcCtD
Hydromorphone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000593	CcSEcCtD
Hydromorphone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000593	CcSEcCtD
Hydromorphone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000593	CcSEcCtD
Hydromorphone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000592	CcSEcCtD
Hydromorphone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000592	CcSEcCtD
Hydromorphone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000589	CcSEcCtD
Hydromorphone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000581	CcSEcCtD
Hydromorphone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00058	CcSEcCtD
Hydromorphone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000573	CcSEcCtD
Hydromorphone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000571	CcSEcCtD
Hydromorphone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000562	CcSEcCtD
Hydromorphone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000559	CcSEcCtD
Hydromorphone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000556	CcSEcCtD
Hydromorphone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000549	CcSEcCtD
Hydromorphone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000542	CcSEcCtD
Hydromorphone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00054	CcSEcCtD
Hydromorphone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000531	CcSEcCtD
Hydromorphone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000527	CcSEcCtD
Hydromorphone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000522	CcSEcCtD
Hydromorphone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000516	CcSEcCtD
Hydromorphone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000512	CcSEcCtD
Hydromorphone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000501	CcSEcCtD
Hydromorphone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000498	CcSEcCtD
Hydromorphone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000493	CcSEcCtD
Hydromorphone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000488	CcSEcCtD
Hydromorphone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000485	CcSEcCtD
Hydromorphone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000484	CcSEcCtD
Hydromorphone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00048	CcSEcCtD
Hydromorphone—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00048	CcSEcCtD
Hydromorphone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000461	CcSEcCtD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000129	0.00169	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000128	0.00167	CbGpPWpGaD
Hydromorphone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000453	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000127	0.00166	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000126	0.00165	CbGpPWpGaD
Hydromorphone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000446	CcSEcCtD
Hydromorphone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000445	CcSEcCtD
Hydromorphone—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000125	0.00163	CbGpPWpGaD
Hydromorphone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000441	CcSEcCtD
Hydromorphone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000439	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000123	0.00161	CbGpPWpGaD
Hydromorphone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000433	CcSEcCtD
Hydromorphone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000432	CcSEcCtD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00159	CbGpPWpGaD
Hydromorphone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000431	CcSEcCtD
Hydromorphone—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000121	0.00158	CbGpPWpGaD
Hydromorphone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000429	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00012	0.00157	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000119	0.00156	CbGpPWpGaD
Hydromorphone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000422	CcSEcCtD
Hydromorphone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000119	0.00155	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00154	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000117	0.00153	CbGpPWpGaD
Hydromorphone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000416	CcSEcCtD
Hydromorphone—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000117	0.00153	CbGpPWpGaD
Hydromorphone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000415	CcSEcCtD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000116	0.00152	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00152	CbGpPWpGaD
Hydromorphone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000409	CcSEcCtD
Hydromorphone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000409	CcSEcCtD
Hydromorphone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000408	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000406	CcSEcCtD
Hydromorphone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000404	CcSEcCtD
Hydromorphone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000398	CcSEcCtD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000111	0.00145	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000111	0.00145	CbGpPWpGaD
Hydromorphone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000392	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00011	0.00144	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00011	0.00143	CbGpPWpGaD
Hydromorphone—Infection—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00039	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000109	0.00143	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00142	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000109	0.00142	CbGpPWpGaD
Hydromorphone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000386	CcSEcCtD
Hydromorphone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000385	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000108	0.00141	CbGpPWpGaD
Hydromorphone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000383	CcSEcCtD
Hydromorphone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.0014	CbGpPWpGaD
Hydromorphone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000381	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000107	0.0014	CbGpPWpGaD
Hydromorphone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000379	CcSEcCtD
Hydromorphone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000374	CcSEcCtD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000102	0.00133	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000102	0.00133	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000101	0.00132	CbGpPWpGaD
Hydromorphone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000357	CcSEcCtD
Hydromorphone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000357	CcSEcCtD
Hydromorphone—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000355	CcSEcCtD
Hydromorphone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000352	CcSEcCtD
Hydromorphone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.86e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.83e-05	0.00128	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.78e-05	0.00128	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.75e-05	0.00127	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.73e-05	0.00127	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.00127	CbGpPWpGaD
Hydromorphone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.71e-05	0.000345	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.65e-05	0.00126	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.64e-05	0.00126	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.63e-05	0.00126	CbGpPWpGaD
Hydromorphone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000341	CcSEcCtD
Hydromorphone—Rash—Prednisolone—chronic obstructive pulmonary disease	9.58e-05	0.00034	CcSEcCtD
Hydromorphone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.57e-05	0.00034	CcSEcCtD
Hydromorphone—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.51e-05	0.000338	CcSEcCtD
Hydromorphone—Headache—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000338	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.51e-05	0.00124	CbGpPWpGaD
Hydromorphone—Constipation—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000335	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.37e-05	0.00122	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.27e-05	0.00121	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.27e-05	0.00121	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.13e-05	0.00119	CbGpPWpGaD
Hydromorphone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.09e-05	0.000323	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000321	CcSEcCtD
Hydromorphone—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.02e-05	0.00032	CcSEcCtD
Hydromorphone—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.84e-05	0.00115	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.83e-05	0.00115	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.82e-05	0.00115	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.82e-05	0.00115	CbGpPWpGaD
Hydromorphone—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000311	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.76e-05	0.00114	CbGpPWpGaD
Hydromorphone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.00031	CcSEcCtD
Hydromorphone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.00031	CcSEcCtD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.63e-05	0.00113	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.62e-05	0.00113	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	8.59e-05	0.00112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.55e-05	0.00112	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.45e-05	0.0011	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.27e-05	0.00108	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.23e-05	0.00107	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.23e-05	0.00107	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.16e-05	0.00107	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.15e-05	0.00106	CbGpPWpGaD
Hydromorphone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000289	CcSEcCtD
Hydromorphone—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.13e-05	0.00106	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.11e-05	0.00106	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.04e-05	0.00105	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.99e-05	0.00104	CbGpPWpGaD
Hydromorphone—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000281	CcSEcCtD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.81e-05	0.00102	CbGpPWpGaD
Hydromorphone—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000277	CcSEcCtD
Hydromorphone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.76e-05	0.00101	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.75e-05	0.00101	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.67e-05	0.001	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.56e-05	0.000987	CbGpPWpGaD
Hydromorphone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000268	CcSEcCtD
Hydromorphone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.49e-05	0.000979	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.48e-05	0.000977	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.47e-05	0.000975	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.45e-05	0.000974	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.39e-05	0.000965	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.39e-05	0.000965	CbGpPWpGaD
Hydromorphone—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000259	CcSEcCtD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.28e-05	0.000951	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.22e-05	0.000943	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.2e-05	0.00094	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.17e-05	0.000936	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.14e-05	0.000933	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.14e-05	0.000932	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.000928	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.000923	CbGpPWpGaD
Hydromorphone—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000249	CcSEcCtD
Hydromorphone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.000915	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	7.01e-05	0.000915	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.96e-05	0.000909	CbGpPWpGaD
Hydromorphone—Rash—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000247	CcSEcCtD
Hydromorphone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000247	CcSEcCtD
Hydromorphone—Headache—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000246	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.85e-05	0.000895	CbGpPWpGaD
Hydromorphone—Nausea—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000233	CcSEcCtD
Hydromorphone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.51e-05	0.00085	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.48e-05	0.000846	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.45e-05	0.000842	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.37e-05	0.000831	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00083	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.32e-05	0.000826	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.22e-05	0.000813	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.11e-05	0.000797	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.95e-05	0.000778	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.95e-05	0.000777	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.79e-05	0.000756	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.76e-05	0.000753	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.71e-05	0.000746	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.65e-05	0.000738	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.54e-05	0.000724	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.47e-05	0.000715	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.46e-05	0.000712	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.44e-05	0.000711	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.38e-05	0.000702	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.3e-05	0.000693	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.22e-05	0.000682	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.22e-05	0.000681	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.19e-05	0.000678	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.16e-05	0.000674	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.95e-05	0.000647	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.94e-05	0.000645	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.94e-05	0.000645	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.87e-05	0.000637	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.77e-05	0.000623	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.69e-05	0.000613	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.69e-05	0.000612	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000612	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	4.64e-05	0.000606	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.000603	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.61e-05	0.000602	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.41e-05	0.000576	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.41e-05	0.000576	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.35e-05	0.000569	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.33e-05	0.000566	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.33e-05	0.000565	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	4.23e-05	0.000553	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.19e-05	0.000547	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.07e-05	0.000532	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.05e-05	0.000529	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.03e-05	0.000527	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.9e-05	0.000509	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.83e-05	0.0005	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.82e-05	0.000499	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.82e-05	0.000499	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.79e-05	0.000494	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.78e-05	0.000494	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.000492	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.00049	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.74e-05	0.000488	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.71e-05	0.000485	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.68e-05	0.000481	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.66e-05	0.000478	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.55e-05	0.000463	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000461	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.45e-05	0.000451	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.45e-05	0.000451	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.42e-05	0.000447	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.36e-05	0.000439	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.34e-05	0.000436	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.28e-05	0.000428	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.25e-05	0.000425	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.23e-05	0.000421	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.21e-05	0.000419	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000415	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.000399	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.03e-05	0.000396	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3e-05	0.000392	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000391	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.95e-05	0.000385	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.93e-05	0.000382	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.92e-05	0.000381	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.00037	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.77e-05	0.000361	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.73e-05	0.000356	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.71e-05	0.000354	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.68e-05	0.00035	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.66e-05	0.000347	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000346	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.62e-05	0.000342	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.56e-05	0.000334	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000326	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.49e-05	0.000325	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000323	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000318	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000317	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.38e-05	0.000311	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000302	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000296	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000295	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.25e-05	0.000294	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000291	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000283	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.13e-05	0.000278	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000266	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.000265	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000263	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.01e-05	0.000263	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000262	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.99e-05	0.00026	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.000256	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000252	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.87e-05	0.000244	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000242	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000241	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000239	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000237	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.000236	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.78e-05	0.000233	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000224	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.00022	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000218	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000216	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.63e-05	0.000213	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.58e-05	0.000207	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.58e-05	0.000206	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000205	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.51e-05	0.000197	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.5e-05	0.000196	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000196	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.47e-05	0.000191	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.43e-05	0.000187	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.000184	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000182	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.000181	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.00018	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000176	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.34e-05	0.000175	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000173	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.32e-05	0.000172	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000171	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000169	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.28e-05	0.000168	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000167	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000166	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.00016	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000159	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.21e-05	0.000158	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000156	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.18e-05	0.000154	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.16e-05	0.000151	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000144	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.09e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.97e-06	0.00013	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.77e-06	0.000128	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.71e-06	0.000127	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.2e-06	0.00012	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.07e-06	0.000118	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.89e-06	0.000116	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.45e-06	0.00011	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.33e-06	0.000109	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.26e-06	0.000108	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.2e-06	0.000107	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-06	0.000105	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.97e-06	0.000104	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.9e-06	0.000103	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.51e-06	9.81e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	7.11e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	6.8e-05	CbGpPWpGaD
